In July 2025, multiple federal agencies announced a reinterpretation of provisions of the Personal Responsibility and Work Opportunity ...

To many at OHSU, it seems he’s listening, like he cares, like he wants to be their champion. He will need every bit of that goodwill.

Let’s talk about 340B, the drug pricing problem that you may not have heard of, but the one that seems to have swallowed the federal budget. The program started as an attempt to help hospitals that ...

Katherine Denney, Gregory Fliszar Ph.D. A federal judge temporarily blocked the Health Resources and Services Administration (HRSA) from implementing its 340B Rebate Pilot Program (Rebate Program or ...

A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal ...

The gaming doesn’t stop there. Some large hospital systems have figured out how to rebrand urban hospitals as “rural” facilities to qualify for government cash reimbursements intended for rural ...

BANGOR, Maine — The Trump administration is temporarily barred from launching its 340B Rebate Model Pilot Program on Jan. 1, 2026, a federal judge ruled. The program would change the upfront drug ...

A federal judge in Maine has temproarily barred the Trump administration from implementing a new 340B drug rebate program for hospitals that was set to take effect on Jan. 1. The judge stated that the ...

The Department of Health and Human Services appears willing to take its contentious 340B Rebate Model Pilot Model back to the drawing board. After a lawsuit filed by hospitals secured a last-minute ...

In the Jan. 1 op-ed “Trump’s chips to China deal compromises national security,” author Tom Jurkowsky poses the question, “Why would the president give away one of America’s technological advantages ...

According to one expert at Pitchbook, two core issues are likely to dominate healthcare reform discussions in 2026: rising costs and flaws in Medicare Advantage. Healthcare affordability remains a ...